Article 29 May 2023 Déjà Vu: The Supreme Court Ignores The Solicitor General's Invitation To Revisit Section 101 . . . Again. United States IP
Article 10 Sep 2019 Federal Circuit Improves The Short-Term "Forecast" For The Doctrine Of Equivalents United States IP
Article 20 Jun 2017 Supreme Court Limits Patent Owners' Ability To Control Post-Sale Use Of Patented Products United States IP
Article 31 Mar 2017 Supreme Court Holds Equitable Laches Is No Longer Available To Limit Patent Damages United States IP
Article 10 Mar 2017 Limiting Extraterritorial Reach Of U.S. Patents: "Substantial" Means More Than One United States IP
Article 10 Mar 2017 Limiting Extraterritorial Reach Of U.S. Patents: "Substantial" Means More Than One United States IP
Article 13 Jul 2016 Federal Circuit Offers Path Through Section 101 Thicket For Biotech Method Patents United States IP
Article 12 Jul 2016 Federal Circuit Invites FDA's Early Licensure Of Biosimilars To Encourage Pre-Launch Resolution Of Patent Disputes United States Healthcare
Article 29 Jun 2016 Supreme Court Defers To The Patent Office On Institution And Management Of Post-Grant Proceedings United States IP
Article 28 Jun 2016 Objective Reasonableness Can Be Central To Fee-Shifting Analysis In Copyright Cases United States IP
Article 09 May 2016 Federal Circuit Denies TC Heartland's Petition To Change The Venue Standard, Renewing Interest In Congressional Venue Reform United States IP
Article 27 Jul 2015 A Fractured Federal Circuit Panel Interprets The Biosimilars Patent Resolution Procedures United States IP
Article 26 Feb 2015 Divided Federal Circuit Panel Upholds Patent Office’s "Broadest Reasonable Interpretation" Standard For Construing Claims In Post-Grant Review United States IP
Article 02 Feb 2015 Supreme Court Calls For Greater Deference To District Court Claim Construction United States IP
Article 30 Dec 2014 Federal Circuit’s Sandoz v. Amgen Decision Forecloses Early Declaratory United States IP
Article 30 Dec 2014 Federal Circuit’s Sandoz v. Amgen Decision Forecloses Early Declaratory Judgment Suits By Biosimilars Applicants United States IP
Article 10 Jun 2014 Supreme Court Decision Invites More Challenges To Patent Claims As Indefinite United States IP